Should you buy into InvoCare Limited's US expansion plans?

I personally would wait for a better price before picking up shares in InvoCare Limited (ASX:IVC).

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

As announced in February's investor presentation and covered in Fairfax media yesterday, ASX-listed funeral operator InvoCare Limited (ASX: IVC) has announced plans to enter the US market.

Estimated to cost US$8 million in total over a three-year 'start up and proving' stage, the recent acquisition of a Californian crematorium is intended to see if InvoCare could expand to capture a larger part of the US market.

Given that two major operators in the US market recently consolidated, InvoCare CEO Andrew Smith was quoted by Fairfax as being optimistic on the opportunities available for smaller players, and the blue-sky potential of the estimated US$18 billion funeral industry.

InvoCare's newly minted US operations began in February this year, and are not expected to break even until the fourth year of operation (2019). However if the entry is successful, InvoCare will have plenty of opportunity to grow both acquisitively and organically.

Given that InvoCare currently trades on a price to earnings (P/E) ratio of around 26, a good deal of growth potential is seemingly priced into the company already, and I would go so far as to say that InvoCare looks quite expensive on the face of its existing businesses, which grew earnings per share by 11.4% in Financial Year (FY) 2014.

Other comparable companies, like Lifehealthcare Group Limited (ASX:LHC), trade on a much lower P/E and offer comparable growth to InvoCare while retaining similar defensive characteristics around demand for their products.

While the US market does have the potential to justify InvoCare's high P/E, it will be several years before the expansion starts to bear fruit and I feel that there is better value to be achieved elsewhere on the ASX in the meantime.

One stock I'm watching closely at the moment is The Motley Fool's Top Dividend Stock for 2015, an impressive holding company that continues to grow earnings and offers good diversification and growth potential to investors despite the recent run-up in price.

To find out more, simply click on the link below and enter your email address to receive your FREE report on just how this company fended off dozens of competitors to be selected as TMF's Top Dividend Stock for 2015.

Sean O'Neill owns shares in Lifehealthcare Group Ltd. The Motley Fool has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »